452 related articles for article (PubMed ID: 35139036)
1. SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
Mazzoni A; Vanni A; Spinicci M; Lamacchia G; Kiros ST; Rocca A; Capone M; Di Lauria N; Salvati L; Carnasciali A; Mantengoli E; Farahvachi P; Zammarchi L; Lagi F; Colao MG; Liotta F; Cosmi L; Maggi L; Bartoloni A; Rossolini GM; Annunziato F
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35139036
[TBL] [Abstract][Full Text] [Related]
2. Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
Almendro-Vázquez P; Chivite-Lacaba M; Utrero-Rico A; González-Cuadrado C; Laguna-Goya R; Moreno-Batanero M; Sánchez-Paz L; Luczkowiak J; Labiod N; Folgueira MD; Delgado R; Paz-Artal E
Front Immunol; 2022; 13():981350. PubMed ID: 36059485
[TBL] [Abstract][Full Text] [Related]
3. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
Front Immunol; 2021; 12():802858. PubMed ID: 35003131
[TBL] [Abstract][Full Text] [Related]
4. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
[TBL] [Abstract][Full Text] [Related]
5. Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.
Glück V; Tydykov L; Mader AL; Warda AS; Bertok M; Weidlich T; Gottwald C; Köstler J; Salzberger B; Wagner R; Koller M; Gessner A; Schmidt B; Glück T; Peterhoff D
Infection; 2022 Dec; 50(6):1475-1481. PubMed ID: 35403960
[TBL] [Abstract][Full Text] [Related]
6. Rapid induction of antigen-specific CD4
Painter MM; Mathew D; Goel RR; Apostolidis SA; Pattekar A; Kuthuru O; Baxter AE; Herati RS; Oldridge DA; Gouma S; Hicks P; Dysinger S; Lundgreen KA; Kuri-Cervantes L; Adamski S; Hicks A; Korte S; Giles JR; Weirick ME; McAllister CM; Dougherty J; Long S; D'Andrea K; Hamilton JT; Betts MR; Bates P; Hensley SE; Grifoni A; Weiskopf D; Sette A; Greenplate AR; Wherry EJ
Immunity; 2021 Sep; 54(9):2133-2142.e3. PubMed ID: 34453880
[TBL] [Abstract][Full Text] [Related]
7. Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
Pušnik J; König J; Mai K; Richter E; Zorn J; Proksch H; Schulte B; Alter G; Streeck H
J Virol; 2022 Aug; 96(15):e0076022. PubMed ID: 35862718
[TBL] [Abstract][Full Text] [Related]
8. Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19.
Lozano-Rodríguez R; Valentín-Quiroga J; Avendaño-Ortiz J; Martín-Quirós A; Pascual-Iglesias A; Terrón-Arcos V; Montalbán-Hernández K; Casalvilla-Dueñas JC; Bergón-Gutiérrez M; Alcamí J; García-Pérez J; Cascajero A; García-Garrido MÁ; Balzo-Castillo ÁD; Peinado M; Gómez L; Llorente-Fernández I; Martín-Miguel G; Herrero-Benito C; Benito JM; Rallón N; Vela-Olmo C; López-Morejón L; Cubillos-Zapata C; Aguirre LA; Fresno CD; López-Collazo E
Cell Rep; 2022 Jan; 38(2):110235. PubMed ID: 34986327
[TBL] [Abstract][Full Text] [Related]
9. Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.
Paniskaki K; Anft M; Meister TL; Marheinecke C; Pfaender S; Skrzypczyk S; Seibert FS; Thieme CJ; Konik MJ; Dolff S; Anastasiou O; Holzer B; Dittmer U; Queren C; Fricke L; Rohn H; Westhoff TH; Witzke O; Stervbo U; Roch T; Babel N
Front Immunol; 2022; 13():816220. PubMed ID: 35145522
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Evolution and Patient Immunological History Shape the Breadth and Potency of Antibody-Mediated Immunity.
Manali M; Bissett LA; Amat JAR; Logan N; Scott S; Hughes EC; Harvey WT; Orton R; Thomson EC; Gunson RN; Viana M; Willett B; Murcia PR
J Infect Dis; 2022 Dec; 227(1):40-49. PubMed ID: 35920058
[TBL] [Abstract][Full Text] [Related]
11. Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.
Glück V; Grobecker S; Köstler J; Tydykov L; Bertok M; Weidlich T; Gottwald C; Salzberger B; Wagner R; Zeman F; Koller M; Gessner A; Schmidt B; Glück T; Peterhoff D
Infection; 2022 Apr; 50(2):439-446. PubMed ID: 34562263
[TBL] [Abstract][Full Text] [Related]
12. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort.
Vo HTM; Maestri A; Auerswald H; Sorn S; Lay S; Seng H; Sann S; Ya N; Pean P; Dussart P; Schwartz O; Ly S; Bruel T; Ly S; Duong V; Karlsson EA; Cantaert T
Front Immunol; 2022; 13():817905. PubMed ID: 35185909
[TBL] [Abstract][Full Text] [Related]
13. Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination.
Barateau V; Peyrot L; Saade C; Pozzetto B; Brengel-Pesce K; Elsensohn MH; Allatif O; Guibert N; Compagnon C; Mariano N; Chaix J; Djebali S; Fassier JB; Lina B; Lefsihane K; Espi M; Thaunat O; Marvel J; Rosa-Calatrava M; Pizzorno A; Maucort-Boulch D; Henaff L; Saadatian-Elahi M; Vanhems P; Paul S; Walzer T; Trouillet-Assant S; Defrance T
Sci Transl Med; 2023 Mar; 15(687):eade0550. PubMed ID: 36921035
[TBL] [Abstract][Full Text] [Related]
14. Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.
Rodda LB; Morawski PA; Pruner KB; Fahning ML; Howard CA; Franko N; Logue J; Eggenberger J; Stokes C; Golez I; Hale M; Gale M; Chu HY; Campbell DJ; Pepper M
Cell; 2022 Apr; 185(9):1588-1601.e14. PubMed ID: 35413241
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactive humoral and CD4
Martel F; Cuervo-Rojas J; Ángel J; Ariza B; González JM; Ramírez-Santana C; Acosta-Ampudia Y; Murcia-Soriano L; Montoya N; Cardozo-Romero CC; Valderrama-Beltrán SL; Cepeda M; Castellanos JC; Gómez-Restrepo C; Perdomo-Celis F; Gazquez A; Dickson A; Brien JD; Mateus J; Grifoni A; Sette A; Weiskopf D; Franco MA
Front Immunol; 2023; 14():1241038. PubMed ID: 37575243
[TBL] [Abstract][Full Text] [Related]
16. Protective Immunity of COVID-19 Vaccination with ChAdOx1 nCoV-19 Following Previous SARS-CoV-2 Infection: A Humoral and Cellular Investigation.
Azamor T; Horbach IS; Brito E Cunha D; Melgaço JG; Silva AMVD; Tubarão LN; Azevedo AS; Santos RT; Alves NDS; Machado TL; Silva J; Souza AF; Bayma C; Rocha VP; Frederico ABT; Dias BM; Setatino BP; Denani CB; Campos SPDC; Schwarcz WD; Sucupira MV; Mendes EP; Silva EDD; Barbosa de Lima SM; Ano Bom APD; Missailidis S
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146723
[TBL] [Abstract][Full Text] [Related]
17. Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.
Goel RR; Apostolidis SA; Painter MM; Mathew D; Pattekar A; Kuthuru O; Gouma S; Hicks P; Meng W; Rosenfeld AM; Dysinger S; Lundgreen KA; Kuri-Cervantes L; Adamski S; Hicks A; Korte S; Oldridge DA; Baxter AE; Giles JR; Weirick ME; McAllister CM; Dougherty J; Long S; D'Andrea K; Hamilton JT; Betts MR; Luning Prak ET; Bates P; Hensley SE; Greenplate AR; Wherry EJ
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33858945
[TBL] [Abstract][Full Text] [Related]
18. First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19.
Mazzoni A; Di Lauria N; Maggi L; Salvati L; Vanni A; Capone M; Lamacchia G; Mantengoli E; Spinicci M; Zammarchi L; Kiros ST; Rocca A; Lagi F; Colao MG; Parronchi P; Scaletti C; Turco L; Liotta F; Rossolini GM; Cosmi L; Bartoloni A; Annunziato F;
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33939647
[TBL] [Abstract][Full Text] [Related]
19. Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.
Glöckner S; Hornung F; Baier M; Weis S; Pletz MW; Deinhardt-Emmer S; Löffler B; The CoNAN Study Group
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696428
[TBL] [Abstract][Full Text] [Related]
20. Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses.
Ibarrondo FJ; Hofmann C; Fulcher JA; Goodman-Meza D; Mu W; Hausner MA; Ali A; Balamurugan A; Taus E; Elliott J; Krogstad P; Tobin NH; Ferbas KG; Kitchen SG; Aldrovandi GM; Rimoin AW; Yang OO
ACS Nano; 2021 Jul; 15(7):11180-11191. PubMed ID: 34159781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
